Dysphagia was documented in 38.10% of the stage 4 group, and over half (55.56%) of the stage 4 group had hypertension, and other disorders of fluid, electrolyte and acid–base balance (52.38%), with (60.32%) prescribed ACE-inhibitors. This evidence concerns the gene ACE and hypertensive disorder.